Commercialising a database
In 2013, the advancing genomic revolution was increasing the rate of cancer mutational data available. At the same time, the cancer research community needed an accurate centralised database to aggregate and interrogate relevant data. How could we organise and curate exponentially growing amounts of data and protect this valuable resource of precious data for both academia and industry?
Working closely with COSMIC, Sanger’s Enterprise & Innovation Team devised and implemented a workable solution to help commercialise the COSMIC database.
This case study describes how it was done.
Three ambitious projects to fight malaria
Despite much progress that has been made to battle the disease, it remains a significant global healthcare challenge. It is found in more than 100 countries mainly in tropical regions of the world affecting millions of people; in 2018 an estimated 24 million children under 5 years of age were infected with P.falciparum in sub-Saharan Africa. Sanger’s researchers work towards the application of Sanger’s science in a number of areas such as drug discovery, vaccine discovery, epidemiological surveillance, diagnostics and precision medicine. This case study describes three ambitious Sanger projects focused on battling malaria.
We’ve supported the creation of four spin-out companies to date; to learn more about Congenica, Kymab, Microbiotica and VHSquared
Find out more
Licensing is one way we disseminate knowledge and resources to benefit the scientific community and improve healthcare
Find out more